Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Augustin Boudoussier
Observed names:
A. Boudoussier,
Boudoussier, Augustin, Elie Marc-Hoël
Institutions:
Centre Hospitalier Universitaire de Bordeaux,
Hôpital Cardiologique du Haut-Lévêque,
Centre de Recherche Cardio-Thoracique de Bordeaux,
Centre d'Investigation Clinique Plurithématique de Bordeaux
Observed institutions:
Université de Bordeaux,
Centre Hospitalier Universitaire de Bordeaux,
Hôpital Cardiologique du Haut-Lévêque,
Institut Bergonié,
Centre de Recherche Cardio-Thoracique de Bordeaux,
Centre d'Investigation Clinique Plurithématique de Bordeaux
show all 6
ORCID:
0009-0008-5114-158X
Observed ORCID:
0009-0008-5114-158X
OpenAlex ID:
A5049807804
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
2023
·
E. Pons-Tostivint
, P. Hulo
, et al.
·
Cancer Immunology Immunotherapy
·
27
PDF
COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors
2025
·
Augustin Boudoussier
, Iban Larrouture
, et al.
·
Scientific Reports
·
18
PDF
Heart is a heavy burden: cardiac toxicity in radiation oncology
2024
·
Pierre Pouvreau
, Imed Taleb
, et al.
·
Supportive Care in Cancer
·
10
Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
2021
·
Pauline Henrot
, Fabien Beaufils
, et al.
·
European Respiratory Journal
·
10
PDF
Emergency radiation therapy in modern-day practice: Now or never, or never again ?
2024
·
Margaux Yaouanq
, Nyere Gibson
, et al.
·
Supportive Care in Cancer
·
4
French pulmonologists suffered from impaired health and quality of life due to their work
2024
·
Claire LELOUP
, Damien Basille
, et al.
·
European Respiratory Journal
·
3
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
2023
·
E. Pons-Tostivint
, P. Hulo
, et al.
·
Cancer Immunology Immunotherapy
·
3
PDF
Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities
2025
·
Claire Leloup
, Emilie Mesa
, et al.
·
ERJ Open Research
Étude de l’incidence en vie réelle de l’insuffisance rénale aiguë organique chez les patients recevant une chimiothérapie-immunothérapie en première ligne de traitement pour un CBNPC non épidermoïde
2025
·
C. Chautemps
, M. Wislez
, et al.
·
Revue des Maladies Respiratoires Actualités
Enquête HEALTH French pUlmonoLogist (HEALTHFUL) sur la qualité de vie au travail des pneumologues français
2024
·
D. Basille
, V. Bironneau
, et al.
·
Revue des Maladies Respiratoires Actualités
COPD patients with NSCLC respond better to immune checkpoints inhibitors
2023
·
Augustin Boudoussier
, Iban Larrouture
, et al.
·
European Respiratory Journal
1113P Real-world multicentre cohort of 1L pembrolizumab alone or in combination with platinum-based chemotherapy in NSCLC PD-L1 ≥ 50%
2022
·
E. Pons-Tostivint
, P. Hulo
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
13
Citation count:
75
H-index:
4
I10-index:
4
Year
Topic
Type